Millar J B, Rozengurt E
Imperial Cancer Research Fund, Lincoln's Inn Fields, London, United Kingdom.
J Biol Chem. 1990 Jul 15;265(20):12052-8.
Prolonged exposure (40 h) of Swiss 3T3 cells to bombesin induced homologous desensitization to bombesin and structurally related peptides including mammalian gastrin releasing peptide (GRP). The ability of bombesin to mobilize intracellular Ca2+, inhibit epidermal growth factor binding, and stimulate DNA synthesis was profoundly and selectively inhibited. In contrast, Ca2+ mobilization by either vasopressin or bradykinin was unaffected, indicating that chronic desensitization is mechanistically distinct from acute desensitization of Ca2+ mobilization. Prolonged (24 or 40 h) pretreatment with bombesin also induced a 78 +/- 5% loss of bombesin receptor binding sites in both intact and plasma membrane preparations of Swiss 3T3 cells without an apparent change in receptor affinity (Kd = 1.9 +/- 0.1 x 10(-9) M and Kd = 1.8 +/- 0.2 x 10(-9) M for control and pretreated cells, respectively). Loss of 125I-GRP binding was slow and progressive with half-maximal loss of binding occurring after 7 h and maximal after approximately 14 h. Cross-linking of 125I-GRP to intact cultures and membrane preparations revealed an identical time-dependent loss of the Mr = 75,000-85,000 cross-linked band, previously identified as the bombesin receptor. Prolonged exposure of the cells to phorbol 12,13-dibutyrate, epidermal growth factor, cholera toxin, or mitogenic combinations of these agents did not alter 125I-GRP binding. Receptor down-regulation and loss of mitogenic responsiveness to bombesin were: (a) induced in a parallel dose-dependent manner by bombesin (ED50 = 1 nM), GRP (ED50 = 2 nM), and neuromedin B (ED50 = 20 nM), but not by the biologically inactive fragment GRP (1-16); (b) inhibited by the specific bombesin antagonist [Leu13-psi(CH2NH)-Leu14] bombesin, and (c) reversed upon removal of bombesin with a similar time course (full recovery after 15 h). On the basis of these observations, we propose that prolonged pretreatment of Swiss 3T3 cells with bombesin induces homologous desensitization to peptides of the bombesin family by down-regulation of cell surface bombesin receptors.
将瑞士3T3细胞长时间(40小时)暴露于蛙皮素会诱导其对蛙皮素以及包括哺乳动物胃泌素释放肽(GRP)在内的结构相关肽产生同源脱敏。蛙皮素动员细胞内钙离子、抑制表皮生长因子结合以及刺激DNA合成的能力受到了显著且选择性的抑制。相比之下,血管加压素或缓激肽引起的钙离子动员未受影响,这表明慢性脱敏在机制上与钙离子动员的急性脱敏不同。用蛙皮素进行长时间(24或40小时)预处理还会导致瑞士3T3细胞完整制剂和质膜制剂中蛙皮素受体结合位点损失78±5%,而受体亲和力没有明显变化(对照细胞和预处理细胞的解离常数Kd分别为1.9±0.1×10⁻⁹M和1.8±0.2×10⁻⁹M)。¹²⁵I - GRP结合的丧失缓慢且呈进行性,结合丧失一半在7小时后出现,约14小时后达到最大。¹²⁵I - GRP与完整培养物和膜制剂的交联显示,分子量为75,000 - 85,000的交联带出现相同的时间依赖性丧失,该交联带先前被鉴定为蛙皮素受体。将细胞长时间暴露于佛波醇12,13 - 二丁酸酯、表皮生长因子、霍乱毒素或这些试剂的促有丝分裂组合中,不会改变¹²⁵I - GRP结合。受体下调以及对蛙皮素促有丝分裂反应性的丧失:(a)由蛙皮素(半数有效剂量ED50 = 1 nM)、GRP(ED50 = 2 nM)和神经降压素B(ED50 = 20 nM)以平行的剂量依赖性方式诱导,但生物活性片段GRP(1 - 16)不会诱导;(b)被特异性蛙皮素拮抗剂[Leu¹³ - ψ(CH₂NH) - Leu¹⁴]蛙皮素抑制;(c)在去除蛙皮素后以相似的时间进程逆转(15小时后完全恢复)。基于这些观察结果,我们提出用蛙皮素对瑞士3T3细胞进行长时间预处理会通过下调细胞表面蛙皮素受体诱导对蛙皮素家族肽的同源脱敏。